EmeraMed Limited is a privately held biotechnology company based in the Republic of Ireland, with operations in Ireland, Sweden, and the United States. The company's ownership group consists mainly of physicians, dentists, and patients who have previously used its products as dietary supplements. EmeraMed is focused on developing a lipophilic antioxidant capable of penetrating the blood-brain barrier. The company's primary goal is to chelate free iron and various heavy metals, including mercury and lead, which can generate harmful free radicals. By addressing these issues, EmeraMed aims to help healthcare providers restore normal mitochondrial function and enhance overall health.
Modvion AB, founded in 2015 and based in Gothenburg, Sweden, specializes in the design and development of modular wind power towers constructed from renewable composite materials. The company's innovative modular technology simplifies construction logistics by facilitating transportation and installation of towers over 120 meters tall. This approach not only reduces costs associated with traditional steel tower construction but also enhances efficiency in harnessing wind energy. By leveraging engineered wood products, Modvion aims to improve the economic viability of wind power investments for power plant construction businesses, ultimately contributing to a more sustainable energy landscape.
Gedea Biotech
Grant in 2019
Gedea Biotech AB, founded in 2015 and based in Lund, Sweden, focuses on developing an antibiotic-free treatment for vaginal fungal infections, a common issue affecting approximately 75% of women at some point in their lives. The company's key product, GA101, utilizes natural substances to lower vaginal pH, provide physical barrier protection, and inhibit biofilm formation. This innovative approach aims to offer a safe and effective solution for treating and preventing vaginal infections without the use of antibiotics. Gedea Biotech is committed to addressing women's health needs through its unique treatment options.
Raytelligence
Grant in 2019
Raytelligence AB, a subsidiary of Swedish Adrenaline founded in 2015, specializes in developing microwave sensors for the healthcare and industrial markets. The company focuses on vital sign monitoring, offering products such as the RayVS1 sensor, which is capable of monitoring heartbeat, movement, and body position. Raytelligence's innovative solutions include cloud-based signal processing and analysis services, facilitating home monitoring for users. The company has received recognition for its advancements, including a grant from the Swedish Innovation Bureau to support the development of its radar sensor technology. Since its inception, Raytelligence has successfully certified its sensor for home use and established partnerships for sensor development in various applications, including the road construction industry and e-Health initiatives. The team at Raytelligence combines expertise in industrial design and radar signal processing, positioning the company as a key player in the sensor technology sector.
Pila Pharma AB is a clinical stage biotech company based in Malmö, Sweden, focused on developing XEN-D0501, a potent and selective TRPV1 antagonist. This innovative compound is being investigated as a treatment for type 2 diabetes, obesity, and the rare painful condition known as erythromelalgia. XEN-D0501 has undergone testing in over 300 subjects during phase 1 and phase 2 trials, demonstrating a favorable safety profile in healthy volunteers and patients with various conditions, including overactive bladder disease and chronic cough. The compound has shown efficacy in improving glucose-stimulated insulin secretion in type 2 diabetics. Recent preclinical studies have completed successfully without any registered side effects, allowing XEN-D0501 to advance to longer clinical trials. In July 2022, Pila Pharma received US Orphan Drug Designation for this compound in the context of erythromelalgia.
Capitainer AB, based in Stockholm, Sweden, specializes in manufacturing innovative blood collection devices for micro sampling, allowing patients to collect their own volume-defined dried blood spots at home. Founded in 2016, Capitainer's technology offers a more accurate and convenient alternative to traditional blood sampling methods, significantly reducing the need for patients to travel for tests. By facilitating remote blood sample collection that can be sent to laboratories through regular mail, Capitainer enhances the efficiency of healthcare providers and contributes to cost and environmental savings associated with managing conventional blood samples.
ImmuneBiotech
Grant in 2019
ImmuneBiotech AB, founded in 2013 and based in Lund, Sweden, specializes in the research and development of innovative microbiome therapeutics. The company focuses on creating novel probiotics derived from lactic acid bacteria and synbiotic formulations that aim to influence gut microbiota and immune system responses. ImmuneBiotech's therapeutic products include combinations of probiotics, prebiotics, and proteins, specifically designed to address various inflammatory disorders such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. By leveraging its online platform, the company seeks to enable healthcare professionals to prevent and treat autoimmune and other chronic inflammatory conditions effectively.
Goava, founded in late 2016 by Jonas Ehne, Henrik Stridsberg, Carl Hall, and Johan Rogebrant, operates a sales intelligence platform that helps businesses identify and target qualified leads. Utilizing big data and machine learning, Goava's platform provides sales teams with accurate and actionable insights through a user-friendly digital interface. This enables companies to efficiently track leads and customers, streamlining their sales processes. Additionally, Goava has received a publishing certificate from the Swedish Press and Broadcasting Authority, further establishing its presence in the market.
OnDosis is a company focused on transforming medication delivery through its proprietary technology, which allows for flexible and individualized dosing of oral medicines formulated as micro units. The company aims to enhance disease management, support patient adherence, and improve convenience for individuals with conditions such as ADHD, pain management, and organ transplant immunosuppression. By offering improved dosing options, OnDosis seeks to address significant healthcare burdens and ultimately enhance patient outcomes. Founded in 2017 and headquartered in Gothenburg, Sweden, OnDosis emerged from research initiated at AstraZeneca and is supported by strategic partnerships in formulation, device development, regulatory affairs, and business development. The company's innovative dosage manager integrates digital technologies with conventional drug treatments, positioning it to make a meaningful impact in personalized medicine.
BoMill AB specializes in grain quality sorting solutions, focusing on the analysis and separation of granular products such as wheat, durum wheat, barley, and oats. The company offers two main products: TriQ, a large-scale grain quality sorting solution, and IQ, designed for laboratory use. Founded in 2001 by Swedish biochemist Bo Löfqvist, BoMill has extensive expertise in single kernel sorting technology. The company provides additional support services, including customer care and installation, and serves various sectors such as seed cleaning, malt houses, and flour mills. Headquartered in Malmö, Sweden, BoMill markets its technology and know-how across Europe, North America, and Australia, utilizing its own sales organization as well as agents and distributors.
Scandinavian ChemoTech AB is a clinical development company headquartered in Lund, Sweden. It specializes in cancer care and pain management solutions, primarily through its innovative product, IQWave. This electroporation device uses short electric pulses in conjunction with localized or intravenous chemotherapy to treat various cancers, including head and neck squamous cell carcinoma, malignant melanoma, and breast adenocarcinoma, among others. The company's founders bring extensive experience in surgical oncology and clinical research, driving its commitment to advancing cancer treatment through genuine research and clinical trials. ChemoTech markets its products via distribution channels and a network of opinion leaders across regions such as South East Asia, India, and the Philippines. Established in 2013, the company continues to focus on developing effective therapies for cancer patients.
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.
Brain Stimulation
Grant in 2019
Brain Stimulation AB is a Swedish small and medium-sized enterprise established in 2011, focusing on the assessment and rehabilitation of patients recovering from strokes and traumatic brain injuries. The company utilizes advancements in brain plasticity research to offer innovative rehabilitation solutions, particularly for cognitive impairments and attention disabilities, such as Spatial Neglect. By addressing the global need for effective rehabilitation in conditions like stroke, dementia, traumatic brain injuries, and Parkinson's disease, Brain Stimulation employs a concept known as Enriched Rehabilitation. Their approach combines precision diagnostics with individualized care technology, facilitating effective neurological rehabilitation that can be accessed remotely. This method aims to create a motivating rehabilitation environment that leads to proven and lasting improvements in patients' cognitive and motor functions, ultimately enhancing their recovery process.
Minnemera is a company based in Stockholm, Sweden, that specializes in developing digital cognitive screening tools. Founded in 2017, the company focuses on creating neurocognitive tests that automatically compare individual results with normative data and personal baseline values to identify abnormalities. This innovative approach aims to enhance the assessment of cognitive function and support healthcare professionals in diagnosing and monitoring cognitive health.
Polymer Factory
Grant in 2019
Polymer Factory, established in 2006 at the Royal Institute of Technology in Stockholm, Sweden, is a prominent supplier of advanced dendritic and polymeric materials, also offering contract research services. Its product range includes monodisperse dendritic polymers derived from 2,2-bis(methylol)propionic acid, such as biocompatible bis-MPA dendrimers and dendrons. The company specializes in the synthesis of high-quality macromolecules, custom materials, and calibrants for MALDI-ToF. Polymer Factory holds exclusive rights to produce, market, and sell several advanced materials, and it globally supplies polyester (Boltorn™) and polyester amide (Hybrane®) hyperbranched polymers for research purposes.
Ekowasher is a manufacturer and developer based in Stockholm, Sweden, specializing in eco-friendly washing systems. The company designs and produces closed, water-efficient cleaning solutions that minimize environmental impact. Its inaugural product, Hullwasher, was introduced in 2015 for cleaning the bottoms of boats. In 2018, Ekowasher expanded its product line with the launch of Graffiti blades, which are designed for effective graffiti removal on various surfaces. The company focuses on providing environmentally optimized washing systems that significantly reduce water consumption.
Klaria Pharma Holding
Grant in 2018
Klaria Pharma Holding AB is a Swedish pharmaceutical company that specializes in the development and commercialization of innovative rapid-acting products for managing migraine and cancer-related pain. Utilizing a patented drug delivery platform, the company employs an alginate-based polymer film that adheres to the oral mucosa, enhancing the efficacy of well-established pharmaceuticals. Klaria's approach combines advanced technology with proven medications, offering significant benefits and potential applications for patients. The majority of the company's operations are based in Sweden, where it focuses on improving treatment options for pain management.
IRLAB Therapeutics
Grant in 2018
IRLAB Therapeutics AB is a Swedish research and development company focused on creating innovative treatments for neurological disorders, particularly Parkinson’s disease. The company is advancing several drug candidates, including Mesdopetam, a dopamine D3 receptor antagonist, and IRL752, which targets postural dysfunction. Both compounds have successfully completed Phase IIa clinical trials. Additionally, IRLAB is exploring other research programs aimed at addressing neurodegenerative disorders and aging, such as IRL942, P001, and P003, which seeks alternatives to levodopa for Parkinson’s treatment. By focusing on the core dysfunctions associated with Parkinson’s disease and dementias, IRLAB aims to enhance the quality of life for patients suffering from these conditions. The company is headquartered in Gothenburg, Sweden.
Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.
AcouSort is a Swedish company specializing in the development and sale of laboratory products and integrated solutions that utilize ultrasound technology for the separation, washing, and enrichment of biological samples. Its offerings cater to researchers and life science companies, focusing on the automated preparation of samples such as blood cells, bacteria, and extracellular vesicles. The technology is rooted in acoustofluidics research from the esteemed group led by Professor Thomas Laurell at Lund University's Department of Biomedical Engineering. Key products include AcouTrap, AcouWash, and AcouPlasma, which facilitate efficient handling of microscopic particles in microfluidic channels for research and diagnostic applications.
Combain is a prominent geolocation service provider specializing in accurate positioning for connected IoT devices. With one of the largest databases of cell IDs and WiFi information globally, it offers extensive resources for both indoor and outdoor device geopositioning, encompassing over 88 million cell IDs and 1.3 billion WiFi access points from more than 200 countries. The company caters to a diverse clientele, including leading mobile network operators, cybersecurity firms, and IoT device manufacturers. Combain provides its positioning services through a cloud-based API known as Combain CPS API, as well as via its IoT platform, IoTmate.io. Headquartered in Lund, Sweden, with an additional office in Palo Alto, USA, Combain serves customers around the world, enhancing the accuracy and efficiency of mobile device localization.
Stayble Therapeutics
Grant in 2018
Stayble Therapeutics AB is a clinical-stage pharmaceutical company based in Gothenburg, Sweden, focused on developing an innovative injection treatment for chronic low back pain caused by degenerative disc changes. The company's primary product, STA363, is an intradiscally injected formulation designed for patients who do not experience relief from conventional treatments such as analgesics and physiotherapy. This minimally invasive treatment aims to address the underlying causes of discogenic pain by stabilizing the disc and preventing the leakage of inflammatory mediators. STA363 is administered as a single injection, with the potential for long-lasting effects and minimal rehabilitation requirements. The experienced multidisciplinary team behind Stayble Therapeutics includes renowned researchers and seasoned professionals from the pharmaceutical industry, all dedicated to alleviating the suffering of millions impacted by chronic back pain.
Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.
CytaCoat is a private Swedish company headquartered in the Karolinska Institutet Science Park in Solna, established by researchers from the Karolinska Institute and the Royal Institute of Technology. The company focuses on developing an innovative antibacterial coating technology for medical devices aimed at preventing healthcare-associated infections. Their proprietary polymer surface demonstrates effectiveness against several problematic pathogenic bacteria, addressing a significant challenge in healthcare. CytaCoat’s technology is designed to be stable under varying pH and ionic conditions, minimizing the release of potentially toxic components and preventing bacterial colonization without relying on antibiotics, which can lead to resistance. The company operates a fully equipped laboratory for microbiology evaluations and technology optimization, and it has established collaborations with clinical partners at the Karolinska University Hospital. Additionally, CytaCoat works with consultants specializing in regulatory affairs, clinical research, patenting, and specialized analyses to advance their product towards commercial viability and licensing opportunities.
Airmee is a logistics company based in Stockholm, Sweden, specializing in last-mile distribution solutions for e-commerce businesses. Founded in 2016, Airmee offers same-day and express delivery services, utilizing a technology-driven platform that incorporates machine learning and proprietary optimization techniques. This platform allows e-commerce companies to schedule and manage their delivery routes in real time, ensuring efficient and timely service. By focusing on environmentally sustainable practices, Airmee aims to enhance the delivery experience while minimizing the environmental impact of logistics operations. As one of Europe's rapidly growing logistics startups, Airmee is positioned to streamline supply chain processes and improve overall delivery efficiency for its clients.
Cognibotics AB, based in Lund, Sweden, specializes in methods and services aimed at improving the performance and longevity of robotic systems. The company focuses on determining critical robot properties such as backlash, friction, and non-linear compliance, which are essential for effective operation in various applications. Cognibotics offers innovative solutions for joint property assessment that enable robots to function in areas where traditional calibration methods fall short. Additionally, the company provides techniques for monitoring mechanical wear and maintenance needs, enhancing the reliability and cost-effectiveness of robotic systems. By improving accuracy and predictability in robotic joint and link designs, Cognibotics supports the development of both new robots and the programming of cooperative robots, thereby expanding their application potential and lifespan.
Colzyx AB is a biotechnology company based in Lund, Sweden, specializing in innovative wound care solutions. Established in 2012, the company focuses on developing bioactive wound dressings that leverage groundbreaking research from the Medical Faculty at Lund University. Colzyx's products utilize the alpha-3 chain from human collagen VI, which has shown remarkable wound healing and antimicrobial properties. By harnessing powerful biological regeneration mechanisms, these dressings not only accelerate the healing process for both active and chronic wounds but also provide protection against a wide range of bacteria, including multidrug-resistant strains. This approach aims to enhance patient outcomes by promoting rapid wound closure and minimizing the risk of bacterial infections.
Xzero is a Swedish company that has spent 20 years in R&D for a new technology for process water in the micro- and nanoelectronics industries. The basic idea is to recycle the water from waste water into Ultrapure Water. The most recent challenge has been to remove nanoparticles in order to make sure these are not spread in the environment and not enter the Ultrapure Water used in cleaning of the nanoelectronics. Third party tests done by The Royal Institute of Technology and Swedish Environmental Research Institute (Sweden), Clarkson University (US), Manta Inc(US) and Anton Paar (Austria) have confirmed that Xzero technology is more efficient than existing technologies in removing nanoparticles from water. In January 2015, Xzero started to industrialize the technology in co-operation with researchers at the Royal Institute of technology in Stockholm, Sweden and at the leading European organization for microelectronics development – imec in Leuven, Belgium. Testing of the first full scale prototype of the industrialized equipment commenced in August 2016 and final industrialized equipment is slotted to be delivered to imec during the first half of 2019. In order to complement the researchers already working on the project, Xzero is recruiting experienced and professional engineers for the industrialization work and experienced sales people for tha marketing. In the commercialization phaseXzero will continue working with imec. Imec has offices in Belgium, the Netherlands, Taiwan, USA, China, India and Japan and a staff of about 2,400 people including several hundred of industrial residents from leading international nanoelectronics companies. Through imec we will be able to reach the largest part of Xzero’s future customers.
Aqua-Q is a Swedish cleantech company with over 20 years of experience in water management and treatment. The company specializes in developing innovative products and processes aimed at ensuring safe and clean water for drinking, treated wastewater, and reuse. Aqua-Q's systems enable water utility operators to detect waterborne outbreaks in a timely manner, allowing for immediate intervention to minimize potential consequences. The company offers modular ozone disinfection systems and holds patents for technologies that effectively eliminate Legionella bacteria in water systems, as well as cold water disinfection methods that verify and disinfect the cleanliness of tanks and pipes. Their solutions are applicable across various industries, including dairy, breweries, and bottled water manufacturing, and provide critical early warning monitoring and automatic biological sampling for pathogen detection, ensuring proactive management of water quality.
InDex Pharmaceuticals
Grant in 2018
InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).
Gradientech AB is a biotech company based in Uppsala, Sweden, specializing in the development and supply of microfluidic products for analyzing cell migration and behavior in response to signaling gradients. The company offers a range of CellDirector products designed for research applications, including the CellDirector Opal and CellDirector Ruby, which facilitate studies on endothelial cell migration, angiogenesis, and tumor cell behavior. Additionally, Gradientech provides complementary tools such as Gradient Marker solutions for visualizing gradient formation, a syringe pump for precise fluid delivery, and a vacuum pump for conducting experiments at elevated temperatures. The company also features the QuickMIC® system for ultra-rapid antibiotic susceptibility testing, which enhances the capabilities of microbiology labs by delivering reliable minimum inhibitory concentration results swiftly. Gradientech serves scientists across academic, pharmaceutical, and diagnostic markets globally, and its products are available for purchase online. The company was incorporated in 2009.
GPX Medical AB
Grant in 2018
Neola Medical AB is focused on advancing neonatal intensive care through its innovative device, NEOLA. This medical technology offers continuous monitoring of lung function and real-time alerts for life-threatening complications in preterm infants. By measuring changes in lung volume and oxygen gas concentration, NEOLA aims to enhance patient care, reduce the duration of intensive care stays, and improve overall health outcomes for vulnerable newborns. The company is rooted in Sweden's rich history of medical technology innovation, which has significantly contributed to advancements in healthcare.
InfiCure Bio
Grant in 2017
InfiCure Bio is a life science company based in Umeå, Sweden, specializing in the preclinical development and validation of drugs aimed at chronic inflammatory and fibrotic conditions. Founded in 2015, it evolved from a project initiated at the Umeå Biotech Incubator by Prof. Dan Holmberg and Dr. Sofia Mayans, leveraging research from their academic work. The company provides a unique preclinical model that simulates the development of fibrosis in various organs, such as the liver and kidneys, which is often preceded by chronic inflammation. This model allows pharmaceutical companies to test their anti-inflammatory and anti-fibrotic drugs comprehensively. InfiCure Bio's services include the setup, execution, analysis, and reporting of results from these effect tests, thereby supporting the development of therapies for significant medical conditions like chronic liver and kidney diseases.
SAGA Diagnostics
Grant in 2017
SAGA Diagnostics AB is a company specializing in molecular genetic tests and services aimed at enhancing cancer diagnostics and disease monitoring for healthcare providers, biopharmaceutical firms, and academic institutions. Founded in 2016 as a spin-out from a research group at Lund University, SAGA focuses on the analysis of circulating tumor DNA (ctDNA), a critical biomarker for cancer. The company offers a range of services, including gene mutation analysis, chromosome analysis, and non-invasive liquid biopsy testing, which allows for the ultrasensitive detection of actionable mutations. SAGA's proprietary technology supports oncologists and drug developers by enabling the stratification of patient groups and monitoring treatment responses, thereby facilitating more precise cancer medicine and improving patient outcomes. Based in Lund, Sweden, SAGA is driven by a team of experienced scientists and professionals dedicated to advancing cancer research and clinical diagnostics.
Furhat Robotics
Grant in 2017
Furhat Robotics AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing advanced social robotics platforms. The company designs and manufactures development kits that integrate hardware, software, and APIs, enabling users to create AI interfaces with human-like social intelligence and expressiveness. Furhat's robots can display facial expressions and engage in context-aware interactions, catering to diverse markets such as information services, healthcare, education, and more. With over 70 international business partnerships, the company aims to revolutionize human-machine interactions by mimicking human personality, gestures, and intonation.
Rdot Display
Grant in 2017
Rdot Display is a Swedish company focused on transforming the reflective display industry. It specializes in the manufacture of printed displays that are designed to be low power consuming and efficient, catering to small display needs. Rdot's products are environmentally friendly and cost-effective, making them suitable for a variety of applications, including sensors, packaging, disposables, electronic shelf labels, and various consumer electronics. By enabling users to display simple messages with minimal power consumption and cost, Rdot Display aims to provide innovative solutions that meet contemporary demands for sustainability and efficiency.
Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in the development of biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients. The company's work is grounded in extensive scientific research conducted at Uppsala University and the Swedish University of Agriculture.
Zemission AB, based in Lund, Sweden, specializes in the development of innovative catalytic combustion technology aimed at achieving efficient and fuel-independent combustion with minimal emissions. With over a decade of expertise, the company has pioneered a multifuel and low-emission combustion concept, enabling flameless combustion suitable for various applications such as automotive heating, renewable energy, and industrial heating. Zemission's unique approach allows for the combustion of liquid fuels, a significant advancement over traditional methods that typically focus on gaseous fuels. The company holds several patents related to its non-monolith technology, positioning it at the forefront of zero-emission heat solutions.
Excillum is a Swedish company founded in 2007 by researchers from the Royal Institute of Technology in Stockholm, specializing in high-end microfocus and nanofocus X-ray sources. The company launched its first product, the MetalJet, in 2010, which utilizes a unique metal-jet-anode design to achieve over ten times the brightness of conventional X-ray technologies. Excillum's advanced X-ray sources, based on patented liquid-jet target technology, are designed for scientific applications and cater to various industries, including semiconductor, automotive, aerospace, and pharmaceuticals. The company aims to facilitate new scientific discoveries, enhance medical practices, and improve manufacturing processes through the continuous development of its state-of-the-art X-ray technologies.
Ocean Harvesting Technologies AB
Grant in 2017
Ocean Harvesting Technologies AB, founded in 2007 and based in Karlskrona, Sweden, specializes in the development of wave power technology that converts wave energy into electricity. The company's primary product is the Infinity Wave Energy Converter (WEC), which integrates advanced energy storage solutions to enhance power capture and ensure a smoother output. Initial developments included a gravitational energy storage system, which evolved to incorporate a flywheel and infinitely variable transmission for improved force control, akin to Kinetic Energy Recovery Systems used in vehicles. In December 2017, the company finalized the design for the 500 kW Infinity WEC, utilizing a lightweight ball screw actuation system to efficiently translate the buoy's motion into rotary energy. Ocean Harvesting Technologies is currently preparing to build a half-scale test rig for the WEC machinery, which will undergo testing as part of initiatives aimed at validating the technology before deploying it in real-world marine environments.
Klimator AB is a software company based in Gothenburg, Sweden, specializing in road weather information solutions. Founded in 1999 and formerly known as Anfangen 708 AB, the company has developed the Road Condition Data Platform, which utilizes sensor fusion to provide comprehensive road weather data, including current conditions, forecasts, and vehicle information. Klimator's technology aids the winter road industry by enabling informed decision-making regarding snow removal and de-icing. The company is closely linked with the University of Gothenburg and focuses on projects related to traffic safety, climate mapping, and forecasting road conditions. In addition to its work in Sweden, Klimator is involved in international projects aimed at enhancing road climate monitoring, developing intelligent transport solutions, and promoting energy efficiency and sustainability. The company also addresses urban design challenges, particularly concerning comfort climate, wind effects, and environmental factors.
Alelion Energy Systems
Grant in 2017
Alelion Energy Systems AB, based in Nödinge, Sweden, specializes in energy storage solutions and the development of high-performance lithium-ion batteries. Established in 2006 as a spin-out from ETC Batteries and Fuelcells, the company focuses on designing and delivering tailor-made battery systems and power electronics that cater to demanding applications across various industries. Alelion Energy Systems emphasizes the safety and longevity of its lithium-ion cells, which are engineered to offer exceptional cycle performance. The company manages the complete battery subsystem, allowing clients to concentrate on their core products and applications. With a production area of 1600 m² and a team of highly educated employees possessing extensive experience in electronics, software, and mechanical development, Alelion combines robust technical expertise with a commitment to efficient production processes. The company's evolution included a change of ownership in 2007 and a rebranding in 2016, highlighting its continuous growth and innovation in the energy storage sector.
Alzinova AB is a biotechnology company based in Mölndal, Sweden, focused on discovering and developing therapeutics for Alzheimer’s disease. Founded in 2011, the company is leveraging its proprietary AβCC peptide technology to create innovative treatments and diagnostics. Alzinova is primarily developing two key products: ALZ-101, an oligomer-directed vaccine aimed at treating Alzheimer’s, and ALZ-201, a monoclonal antibody that targets toxic oligomeric Aβ species known to damage brain synapses. Both products are currently in various stages of clinical and preclinical development, representing significant advancements in the search for effective Alzheimer’s therapies.
Corline Biomedical
Grant in 2017
Corline Biomedical AB is a pharmaceutical company based in Uppsala, Sweden, specializing in the development, manufacturing, and marketing of heparin-based solutions. Founded in 1991, the company focuses on enhancing kidney transplantation, cell therapies, and regenerative medicine applications. Its product offerings include Renaparin, designed for treating end-stage renal failure; Cytoparin, aimed at treating type 1 diabetes; and CHC, which addresses soft tissue injuries. Additionally, Corline develops medical devices and coronary stents. Through its innovative heparin conjugate technology, Corline Biomedical aims to provide effective solutions in the healthcare sector.
RemoteA Oy is a medical company focused on remote monitoring and consultation services, particularly in the field of cardiac care. Since its establishment in 2002, it has built an extensive network of general practitioners, specialist physicians, and healthcare organizations across Finland, Sweden, and the United Kingdom. The company provides software solutions that analyze long-term ECG data using advanced algorithms and artificial intelligence, facilitating timely treatment for patients. Its platform operates in approximately 300 healthcare units and collaborates with over 20 leading cardiac electrophysiologists. By storing data securely in the cloud, RemoteA Oy enhances the efficiency of healthcare providers and adds value for wellness operators.
SenzaGen AB is a biotechnology company based in Lund, Sweden, specializing in in vitro genomic allergen rapid detection (GARD) sensitization tests. Founded in 2010 as a spin-out from Lund University, SenzaGen provides animal-free testing solutions for the cosmetic, pharmaceutical, and chemical industries, focusing on immunotoxicological assays. Its proprietary product line includes GARDskin, which predicts chemical sensitization, GARDpotency, which classifies sensitizers based on genomic biomarkers, and GARDair, an assay for respiratory sensitizers. The company operates through its own laboratory and collaborates with licensed contract research organizations to deliver its services. SenzaGen also engages in partnerships, such as its collaboration with the Research Institute for Fragrance Materials to develop tests for photosensitization. The company serves multiple market segments, including cosmetics, chemicals, medical devices, pharmaceuticals, and food additives, with a significant portion of its business derived from the pharmaceutical sector.
Biofrigas Sweden AB, located in Gothenburg, Sweden, specializes in the production of biogas, which is utilized in the food and agriculture sectors as well as in wastewater treatment. The company employs a unique technology that enables the upgrading and liquefaction of biogas, catering to small-scale production needs in agriculture and smaller treatment plants. In addition to biogas, Biofrigas also supplies CO2 and heat for various applications, supporting sustainable practices across multiple industries.
Starcounter
Venture Round in 2017
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform aimed at revitalizing enterprise software systems. Its innovative platform integrates an in-memory database engine with an application server, facilitating the creation of high-performance business applications. Starcounter's research and development team, composed of over 30 experts in artificial intelligence, mathematics, and algorithms from seven different countries, drives the company's advancements in technology. By leveraging artificial intelligence and in-memory computing, Starcounter enhances the efficiency and performance of software applications for enterprises.
Signicat
Venture Round in 2017
Signicat is a prominent digital identity service provider in Europe, specializing in electronic identification and e-signature solutions. Founded in 2006, the company originally emerged as Kantega Secure Identity and operates globally, delivering online trust services to both public and private sectors. Signicat's offerings adhere to international standards and regulatory requirements, including privacy laws, anti-money laundering regulations, and Know Your Customer protocols, ensuring secure user onboarding. The company's advanced solutions enable banks, financial institutions, insurance firms, government agencies, and various businesses to authenticate users, facilitate electronic signing, and maintain document integrity. With a focus on enhancing user experience while mitigating risks through cutting-edge security technology, Signicat provides banking-grade service level agreements to meet the needs for scalability and reliability. The company maintains offices across several key European cities, including London, Frankfurt, Amsterdam, Lisbon, Copenhagen, Stockholm, Helsinki, Trondheim, and Oslo.
Marstrom Composite
Venture Round in 2017
Marstrom Composite AB is a Swedish company based in Västervik, founded in 1983, that specializes in the design and manufacture of high-quality composite products. The company produces a range of items, including boats, spars for both monohulls and multihulls, and various industrial components. Marstrom Composite employs advanced autoclave technology to enhance the durability and performance of its products, while also emphasizing sustainable practices. In addition to its core offerings, the company diversifies its portfolio by providing medical equipment, oil prospecting tools, camera bodies, and cargo panels for major aircraft manufacturers such as Boeing and Airbus. Marstrom Composite operates as a joint venture between TBS Group AB and TBS Yard AB.
Carbiotix is a pre-clinical stage therapeutics company based in Sweden, focusing on gut health testing and microbiome modulators to tackle various chronic and metabolic diseases. Founded in 2014, the company emerged from four years of research at Lund University and the Antidiabetic Food Centre. Carbiotix developed a low-cost gut health testing platform, which was launched in 2018 alongside a significant 600-person gut health study. The company’s innovative products include OneGut, MonthGut, LinkGut, and HealthGut, all designed to leverage proprietary soluble fibers and isolated strains. Carbiotix aims to harness the potential of the gut microbiome to improve health outcomes and advance therapeutic development.
Ingrid Cloud
Grant in 2016
Ingrid Cloud AB, based in Stockholm, Sweden, specializes in a cloud-based computational application designed for wind simulation. Founded in 2014, the company offers an automated platform that streamlines the flow simulation and design optimization process. By converting computer-aided design (CAD) geometry into complex simulation models without requiring manual intervention, Ingrid Cloud's technology enhances accuracy, flexibility, and cost efficiency. This user-friendly service allows designers, architects, engineers, and researchers, even those without prior knowledge of computational fluid dynamics, to effectively predict flow and refine their designs.
Nelson Garden
Grant in 2016
In 1933 a seed was born. Then Georg Nilsson sat with family home around the kitchen table and filled small bags of seeds. These seeds would soon be sold and the story of Nelson Garden began. For almost a century, we have grown and developed our business. We love to grow and we are at the same time entrepreneurs. We will take care of that. Thanks to our rich history, Nelson Garden is today the market leader in seed for hobby growers in the Nordic region. The Group has approximately 100 employees and sales of SEK 235 million in 2015. In addition to operations in Sweden, we have sales companies in Denmark, Finland, and Norway. Sales are through trade and grocery stores. In addition to seeds, we also sell onions, bird food and garden accessories.
Clinical Laserthermia Systems
Grant in 2016
Clinical Laserthermia Systems AB is a Swedish company that specializes in the development and marketing of therapies and systems for the thermal treatment of solid cancer tumors. Based in Lund, with subsidiaries in Berlin and Boston, the company offers the TRANBERG Thermal Therapy System, which includes a laser unit with advanced monitoring capabilities and tailored single-use instruments for its immunotherapy method known as imILT. Clinical Laserthermia Systems is also focused on creating innovative solutions for various cancers, including breast, pancreatic, skin, and prostate cancers. The company engages in collaborative efforts with organizations such as Image Guided Therapy SA and MRI Interventions, Inc. to advance software and navigation platforms for laser ablation in various medical applications. Additionally, it participates in clinical trials with institutions like Toronto General Hospital to explore MRI-guided treatments for prostate cancer.
Greenely AB, based in Stockholm, Sweden, develops an innovative application focused on energy management that allows users to monitor their electricity consumption and receive personalized tips for savings. The app connects over 150,000 households, enabling users to control and optimize their energy usage, thereby fostering the creation of zero-emission communities. By utilizing advanced learning algorithms, the application tracks and analyzes energy behaviors, providing targeted feedback and insights without the need for additional hardware. Greenely aims to enhance the experience of modern energy consumers by empowering them with knowledge and tools to manage their energy usage efficiently, ultimately contributing to self-sustainable communities.
NIL Technology ApS
Grant in 2016
NIL Technology ApS specializes in the optical design, prototyping, mastering, and mass production of optical components. The company provides nanostructured masters for various replication technologies, including nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product offerings support a wide range of applications, such as diffractive optics, microlens arrays, metalenses, optical diffusers, beam splitters, waveguides for augmented and mixed reality, wire grid polarizers, structured light systems, and anti-reflection coatings. NIL Technology also develops tailored solutions for industries including biotechnology, space, consumer product packaging, and renewable energy. Established in 2006, the company is headquartered in Kongens Lyngby, Denmark, with an additional branch located in Gothenburg, Sweden.
In&motion is a company that specializes in developing wearable smart protection systems aimed at reducing the risk of serious injuries from falls. The company has created a smart ski airbag vest equipped with advanced sensors and algorithms that monitor a skier's movements in real time. This technology allows the vest to anticipate falls and activate the airbag bladder before impact, providing optimal protection for both broad and critical areas of the body. The smart ski airbag vest has received multiple awards and was used by competitors in the 2015-16 Ski Cross World Cup, representing seven major countries. As of September, the vest became available for purchase through a partnership with the Swedish brand POC, making it accessible to a wider audience of athletes and skiing enthusiasts who prioritize safety.
NeoZeo AB, established in 2010, specializes in biogas upgrading equipment and technologies. Based in Stockholm, Sweden, with an additional office in Riga, Latvia, the company develops innovative solutions for small-scale biogas upgrading using vacuum pressure swing absorption (VPSA) and novel absorbents. NeoZeo's products enable farms and municipalities to convert raw biogas into high-value biomethane, a clean fuel and energy source. The company's expertise lies in structuring and modifying porous materials for gas separation and catalytic applications, with a particular focus on separating carbon dioxide from methane. NeoZeo also offers consulting services in gas separation, nanoparticles, dispersions, and material processing.
Agrisera AB, founded in 1985 and based in Vännäs, Sweden, specializes in the development and production of polyclonal and monoclonal antibodies. The company offers an extensive selection of over 1,000 primary antibodies and more than 2,000 secondary antibodies, catering to various applications and research needs. Agrisera is known for its personalized service, providing direct access to its staff scientists who promptly address client inquiries. The company's focus extends to antibody purification and peptide synthesis, ensuring that clients receive detection reagents tailored to their specific requirements in terms of volume and sensitivity. As a subsidiary of Olink Proteomics AB since May 2020, Agrisera continues to serve the scientific community with its specialized antibody products for detecting plant, algal, and human proteins.
Emotra AB, established in 2001 and based in Sävedalen, Sweden, is a medical device company specializing in the research and development of instruments to measure peripheral psychophysiological signals from the skin. Its primary product, Electrodermal Orientation Reactivity (EDOR), is a psychophysiological test designed to identify patients as reactive or hyporeactive based on their electrodermal reactions to audio stimuli. EDOR is intended for use in psychiatric care and research, providing objective support in routine clinical procedures, particularly for assessing suicide risks in depressed patients.
Optixmarine is a Swedish company that offers a patent pending gearbox for ships.
Sol Voltaics
Venture Round in 2016
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.
Boule Diagnostics
Grant in 2015
Boule Diagnostics is a diagnostic company specializing in the development, manufacturing, and marketing of systems and consumables for hematology. The company primarily serves the decentralized market segment, focusing on small and midsize hospitals, clinics, and laboratories within outpatient care, as well as other diagnostic firms in both human and veterinary hematology. Boule operates through commercial subsidiaries in Sweden, the United States, and China, and its products are distributed globally in over 100 countries. Founded in 1992 with the acquisition of Karo Bio Diagnostics AB, Boule's roots trace back to the 1950s when Erik Öhlin developed Europe’s first automatic blood cell counter. This legacy continues through the innovative instruments offered by Boule today.
BraceIt creates truly original and useful products for the wearable space, such as ReVault - the world's first wearable private cloud. Its experienced team in Sweden have spent years building smartwatches, unmanned helicopters, fighter aircraft, and automated cars with some of the world’s leading engineers and advanced technology. BraceIt is a member company of LEAD, the best awarded incubator in Sweden in 2014.
Foreseeti AB is a technology company based in Stockholm, Sweden, specializing in automated threat modeling and attack simulation solutions. Founded in 2014, the company offers several products, including foreseeti, which allows organizations to model threats and simulate attacks on interconnected IT infrastructures, and securiCAD Vanguard, designed for cloud environments using data from AWS. Additionally, securiCAD Professional enables security architects and IT professionals to create virtual models and conduct simulations on existing and planned architectures, while securiCAD Enterprise provides enterprise-level features for collaboration, automated modeling, and reporting. Foreseeti serves various industries, including military, aviation, finance, energy, automotive, and manufacturing, and distributes its solutions through consultancies and resellers. The company's approach is appreciated for its practical applicability, leveraging AI to enhance cybersecurity management and provide valuable insights.
Arcam AB specializes in additive manufacturing solutions for metal components, primarily focusing on the orthopedic and aerospace industries. The company offers advanced products such as the Arcam Q10, an electron beam melting (EBM) machine designed for the production of orthopedic implants, and the Arcam A2, which facilitates the additive manufacturing of metal parts using various materials for aerospace applications. In addition to these machines, Arcam provides a range of auxiliary equipment for powder handling, including explosion-protected vacuum cleaners, trolleys, and recovery systems. The company also supplies software, metal powders, and a variety of services, including application support and training. Founded in 1997 and headquartered in Gothenburg, Sweden, Arcam serves a global customer base.
SaferMe Limited is a software development company based in Wellington, New Zealand, founded in 2012. It specializes in creating a platform that enhances workplace safety by warning workers of potential hazards and allowing businesses and governments to crowdsource hazard locations. The company offers various services, including offline reporting, system integration, tailored solutions, automatic backups, and map interfacing. SaferMe aims to improve health and safety communication within complex organizations and has a user base spanning over 20 countries. It operates offices in New Zealand, Sweden, and the United Kingdom, collaborating with organizations such as Downer and The Morgan Foundation. Additionally, SaferMe has developed a contact tracing application to help reduce virus transmission while ensuring user privacy through anonymized interaction logging.
Prismatic Sensors
Grant in 2015
Prismatic Sensors AB is a Swedish company based in Stockholm that specializes in the development of advanced sensors for medical x-ray imaging. Established in 2012 as a spin-off from KTH Royal Institute of Technology, the company focuses on creating photon counting detectors designed to enhance contrast and spatial resolution while minimizing radiation exposure for patients. Prismatic Sensors leverages a strong engineering foundation in electronics design, precision mechanics, and data acquisition programming to innovate in the field of medical imaging. The company’s expertise extends to system integration and navigating the regulatory approval process for medical devices, enabling the successful implementation of its products in clinical settings. By transforming fundamental scientific research into practical applications, Prismatic Sensors contributes to improved patient outcomes by aiding healthcare professionals in making informed decisions during diagnostics and treatment.
IBC ROBOTICS AB
Grant in 2015
IBC ROBOTICS AB has developed a robotic cleaner patented in Sweden and other European countries. IBC Robotics was founded in 2010 by Kerstin and Göran Ericsson. The business concept is based on the environmentally friendly cleaning of transport containers using dry ice and a robot. The solution has been developed in collaboration with Robot Valley, the Royal Institute of Technology and Mälardalen University. The first IBC Robotics cleaning solution is now in operation at the Combi Terminal in Eskilstuna where containers are transferred between trucks and trains.
Mobiletech is a software company that provides the tools for companies, content owners and publishers to create content and services on the mobile web. Mobiletech is a global provider of mobile software and services. Our award winning Platform helps businesses engage with customers through mobile solutions that are quick to develop, simple to deploy and cost effective to maintain. The solutions promise to work seamlessly on every mobile device – today and in the future. Established in 2005, our Platform broke new ground by enabling mobile users to navigate the web with the same ease they expected from their PC. Today, the mobile user experience is still at the core of our approach. Making sure that our clients have mobile solutions that give users an unrivalled experience not only increases traffic to their site – it is the key to building customer loyalty and making mobile initiatives profitable. For Mobiletech’s customers, mobile is straightforward because: - We take a holistic view of web, mobile and apps to create the right solution for each one. - Our Platform automatically gives users the best mobile experience regardless of device, browser, the speed of their connection or geographic location. - Our Platform is future compliant – ready to exploit emerging technologies and manage the challenges they create. You can start small and grow with your needs. The Platform scales easily and is built for high volumes and high performance. - Mobile becomes part of your existing work-flows. This ensures editorial flexibility and control, while content is published with no extra work and tools people already know. - Content need only be developed once to reach all mobile channels. - We are experienced at integrating modern mobile solutions with legacy systems. - The solution is simple and cost effective to maintain. - We are flexible and our solutions can support any business and deployment model. - Today, more than 300 companies rely on Mobiletech to power their mobile strategy with solutions that span 60 countries and 57 languages. They include local and global brands in media, telecoms, finance, energy and the public sector. Mobiletech is headquartered in Norway and has offices in Sweden, Denmark and the United States.
Inission is a Swedish company specializing in tailored production and logistics services for advanced industrial electronics. With locations in Stockholm, Malmö, Borås, Munkfors, and Pajala in Sweden, as well as Tallinn in Estonia and a sales office in Copenhagen, Denmark, Inission serves a diverse range of industrial customers. The company focuses on developing and managing complete electronic products throughout their entire life cycle, ensuring that clients receive comprehensive support from production to logistics.
Nordic Solar Sweden AB
Grant in 2015
Nordic Solar Sweden AB with the roots in Värmland, Nordmarken, has installed solar cell installations on the Swedish solar cell market since 2009. The head office is located in Töcksfors and we have a branch in Karlstad. We store solar cells, inverters and assembly materials for immediate delivery for the Swedish and Norwegian markets.
In&motion is a company that specializes in developing wearable smart protection systems aimed at reducing the risk of serious injuries from falls. The company has created a smart ski airbag vest equipped with advanced sensors and algorithms that monitor a skier's movements in real time. This technology allows the vest to anticipate falls and activate the airbag bladder before impact, providing optimal protection for both broad and critical areas of the body. The smart ski airbag vest has received multiple awards and was used by competitors in the 2015-16 Ski Cross World Cup, representing seven major countries. As of September, the vest became available for purchase through a partnership with the Swedish brand POC, making it accessible to a wider audience of athletes and skiing enthusiasts who prioritize safety.
Cinnober Financial Technology
Grant in 2015
Cinnober Financial Technology AB is a provider of advanced technology solutions for exchange trading, risk management, and financial services globally. Established in 1998 and headquartered in Stockholm, Sweden, Cinnober offers a comprehensive suite of products including the TRADExpress Trading System, a multi-asset trading platform, and the TRADExpress Index Engine, which facilitates real-time index calculation and distribution. The company also provides market data distribution through the TRADExpress Information Manager, as well as surveillance and compliance solutions such as Irisium. Cinnober's offerings extend to clearing solutions, including TRADExpress RealTime Clearing and TRADExpress CCP Risk, catering to the needs of marketplaces, clearinghouses, banks, and brokers. The company has established a strong reputation through successful projects with prominent financial institutions and continues to focus on innovation in trading and clearing technologies.
Parans Solar Lighting
Grant in 2015
Parans Solar Lighting specializes in providing natural light solutions for indoor environments through a patented system that captures and transports sunlight. Founded in 2002, the company commercialized its first technology in 2004 after extensive research and development in collaboration with Chalmers Technical University in Sweden. Parans targets building owners, architects, and private individuals worldwide, offering products that promote energy efficiency and enhance indoor quality. The company aims to improve indoor environments, particularly in spaces like classrooms, by maximizing the use of natural light while ensuring effective use of materials in large building construction.
Avantherm is a Swedish company which develops and sells renewable, high-performance alternatives to the fossil oils and chemicals currently in use. Avantherm’s products are sold under the Avantherm brand, and have been developed and tested jointly with partners such as KTH Royal Institute of Technology in Stockholm and Saybolt, as well as several leading institutes in Europe. By offering next-generation high-performance oils and chemicals, Avantherm is playing its part in achieving a fossil-free and sustainable society.
Enza Biotech
Grant in 2015
Enza Biotech AB is a biotechnology company based in Lund, Sweden, founded in 2012. It focuses on researching and developing renewable surfactants through carbohydrate-based chemistry, positioning itself at the intersection of science and business. The company aims to facilitate the transition from fossil fuels to a biobased society by creating innovative bio-based non-ionic surfactants. These surfactants, derived from alkylglycosides and oligomeric alkylglycosides, are designed for use in cosmetics, personal care products, and pharmaceuticals. Enza Biotech leverages its proximity to Lund University and combines insights into industrial challenges with molecular understanding to meet market needs effectively.
Aasa Global is an international financial technology company founded in 2011, specializing in providing credit solutions to consumers and small to medium-sized businesses. Operating in countries such as Estonia, Poland, Finland, Sweden, Chile, and Indonesia, Aasa seeks to expand into high-growth markets by developing innovative financing solutions. The company utilizes a proprietary, fully automated lending platform that leverages predictive analytics to facilitate quick market entry and scalability. Aasa’s business model has been tested in various regions, focusing on offering financial support where traditional banks may lack speed and flexibility. The company emphasizes client service as its most valuable asset, aiming to provide accessible financial assistance through a unique multi-stage credit assessment process for both individual clients and business owners.
Salixenergi Europa
Grant in 2015
Salixenergi Europa has been working with energy willow since 1986. Its professional expertise ranges over a wide spectrum, from early planting trials to advanced technological developments in planting, harvesting, and handling. Stable, sustainable plant breeding for over 25 years has produced new willow varieties that provide superior yields. SalixEnergi Europa AB and the plant breeder division of the national Swedish farmers association Lantmännen SW Seed are working together to continuously improve cultivation supplies and cultivation technology. Lantmännen SW Seed has been working with plant breeding for 130 years and commercial willow breeding since 1987. SEE is a privately owned incorporated company with its head office located in southern Sweden. SEE is the representative, both directly and via licensed producers, for the superior willow varieties bred by Lantmännen SW Seed for the European market. Through entrepreneur networks and transport logistics networks, SEE has the capability to manage the harvesting and sales of the willow chips and the delivery of the chips to power stations.
Time Critical Networks
Grant in 2015
Time Critical Networks (TCN) is a Swedish startup focused on creating software solutions that help networks adapt to the specific needs of various applications. The company specializes in developing simulation tools for evaluating next-generation Ethernet-based architectures. TCN's software allows customers to design cost-effective and reliable Ethernet networks while ensuring performance metrics such as latency, jitter, and packet delivery are met. Their flagship product, TCN TimeAnalysis™, is currently in public BETA testing and offers model-based performance simulation and analysis for real-time traffic streams. Originating from Chalmers Ventures, a prominent incubator in Scandinavia, TCN aims to empower businesses to optimize system timing and performance throughout the entire network development process.
Ferentis is a research-intensive biotechnology company involved in the development, production and commercialization of biomimetic peptides and peptide-based scaffolds for tissue engineering and regenerative medicine applications. Ferentis was established in Vilnius, Lithuania, by a group of scientists and entrepreneurs from Canada, Lithuania, Sweden and India.
Made for Movement
Grant in 2015
Made for Movement is a developer and manufacturer of therapeutic equipment designed to enhance mobility for individuals with severe disabilities, particularly children and young adults. Founded in 1995 by Norwegian entrepreneurs Ånund Olsen and Erik Vegge, the company gained initial momentum with the launch of the NF-Walker in 1996, following a partnership with medical technology developer David Hart. The Innowalk, a significant innovation introduced after Olsen's success in a Norwegian entrepreneurial competition in 2007, has since become a key product, with various models tailored to meet diverse needs. The Innowalk Pro, launched in 2011, and the next-generation NF-Walker 2, introduced in 2016, exemplify the company's commitment to continuous improvement. Headquartered in Norway, Made for Movement operates additional offices in Germany, Sweden, Denmark, and the Netherlands, and has expanded its reach to 14 other countries, serving thousands of users globally as a leader in mobility solutions for those with disabilities.
Solvatten is water treatment and solar water heating in one that prevents people from falling sick and improves the quality of life. Solvatten is a Swedish social enterprise that brings Solvatten Solar Safe Water System to customers, charities and distributors around the world. We also partner with organisations and micro-finance institutions to increase reach and affordability. Solvatten is the brainchild of the Swedish inventor, Petra Wadström. The story began in Australia in the early 90s, where Petra was living with her husband Carl and their family. The Wadström’s professional background was diverse, spanning both medical science and the arts. A charitable branch of Solvatten was founded in 2013, focused on improving the lives of, above all, women and children, living without access to safe water. Contributions made in the US are administered by the Solvatten Charitable Foundation USA, a registered 501(c)(3) organization. Contributions to Solvatten Charitable Foundation USA are tax deductible to the extent permitted by law. Living in Australia, Petra was struck by the abundance and intensity of natural sunlight. She was convinced that it must be possible to harness its strength for the betterment of those living in poverty. Exposure to sunlight was key, as this has the effect of both purifying and heating water. After succesful initial trials of the device several field visits throughout Africa and Asia took place, where Petra and her team began conducting studies to validate the efficacy of her creation in a variety of contexts. Today, Solvatten is used in more than 20 countries around the world reaching more than 260.000 people.
Watty AB is a Swedish company that specializes in energy management solutions for both businesses and private individuals. Founded in 2013 and headquartered in Stockholm, Watty offers an innovative product known as NILS, which involves installing a device on the electricity meter to monitor energy consumption. This solution utilizes machine learning algorithms to analyze aggregate energy data, breaking it down into detailed insights about individual appliances and their usage patterns. Watty's subscription-based service provides users with real-time information through a dedicated app, enabling them to make informed decisions about their energy consumption while promoting sustainability. The company's technology integrates various disciplines, including artificial intelligence, hardware, and the Internet of Things, to enhance the user experience and support energy efficiency.
Mantex
Venture Round in 2015
Mantex AB manufactures and sells industrial X-ray scanners, primarily serving the bioenergy, pulp and paper, and research sectors both in Sweden and internationally. Established in 1987 and based in Kista, Sweden, the company specializes in biofuel analyzers that evaluate the quality of wood-based biofuels, as well as flow scanners designed to assess wood chips for pulp and paper production. Mantex's innovative technology enables real-time analysis of organic materials used in various industrial processes, helping to identify foreign objects and measure material properties effectively. This capability is particularly important in addressing the challenges posed by variations in the water content of raw materials, which can impact the purchasing and processing of organic matter in large quantities.
Mandalon Technologies
Grant in 2015
Mandalon Technologies offers electronic packaging partner from prototype to production. company with special knowledge The company was founded in 1999 with roots in the sensor business S-SENCE at Linköping University. Since then, the company has involved the assembly and wire bonding of sensors, MEMS structures and ASICs and in 2001 Mandalon's first own assembly lab was built. In 2002, Mandalon Corporation and ISO 9001: 2008 certification were active 2008-2015. From 2017 we are certified according to ISO 9001: 2015. Mandalon has been an active member since the start of the Swedish Electronics Industry Association.
Azelio AB, a Swedish company, specializes in renewable energy solutions utilizing Stirling engine technology. The company addresses the challenge of harnessing solar energy for continuous electricity supply, even during non-sunny hours. Azelio offers a system designed for projects in the global energy market, particularly in sunbelt regions, with installations ranging from 500 kW to 20 MW. This system combines electrical production during the day with a storage capacity of up to 13 hours. Azelio derives most of its revenue from the European Union while also operating in Sweden and other countries, aiming to provide sustainable and cost-effective energy storage solutions.
ClimateWell AB, the Solar Cooling company, from Sweden and its business partners develop and market energy efficient indoor climate solutions for use in hotels, condos, blocks of flats, high end villas, office buildings, nursing homes and hospital buildings. Its triple state absorption process is a patented technology which transforms heat into cooling without using electricity. ClimateWell AB and its management team received various international awards and recognitions for their innovation. The company offers its solutions through its partners around the world.
Finepart Sweden
Grant in 2014
Finepart Sweden AB specializes in the design and manufacture of fine and micro-abrasive waterjet machines, catering to precision cutting, drilling, milling, and turning. The company's technology enhances product performance and manufacturing flexibility, particularly in sectors such as medical technology, aerospace, fiber-reinforced products, and micro components. Finepart's offerings include various models like the finecut WMC 500II and additional options, all aimed at providing solutions for intricate machining tasks. The company also addresses the need for polishing and deburring of complex-shaped parts, leveraging innovation and expertise to help customers improve their competitiveness in the global market.